Blueshift Asset Management’s Zimmer Biomet ZBH Stock Holding History

Blueshift Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,550	Closed	-$602K	–	490
2024 Q2	$602K	Buy	+5,550	New	+$654K	0.2%	141
2024 Q1	–	Sell	-2,794	Closed	-$340K	–	385
2023 Q4	$340K	Sell	2,794 -2,525	-47%	-$282K	0.18%	167
2023 Q3	$597K	Buy	+5,319	New	+$675K	0.35%	77
2022 Q4	–	Sell	-3,907	Closed	-$408K	–	686
2022 Q3	$408K	Buy	+3,907	New	+$429K	0.09%	328
2022 Q1	–	Sell	-1,827	Closed	-$225K	–	1166
2021 Q4	$225K	Sell	1,827 -39,707	-96%	-$5.2M	0.02%	722
2021 Q3	$5.9M	Sell	41,534 -10,349	-20%	-$1.52M	0.33%	66
2021 Q2	$8.1M	Buy	+51,883	New	+$8.4M	0.44%	58
2021 Q1	–	Sell	-9,735	Closed	-$1.46M	–	1110
2020 Q4	$1.46M	Buy	+9,735	New	+$1.37M	0.17%	187
2019 Q1	–	Sell	-2,295	Closed	-$231K	–	969
2018 Q4	$231K	Buy	+2,295	New	+$258K	0.04%	547

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Blueshift Asset Management's ZBH Position: Q3 2024 in Review

Blueshift Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 5,550 shares — an estimated $602K sold.

Blueshift Asset Management first reported a position in ZBH in Q4 2018 and held it in 9 quarters. The position peaked at $8.1M in Q2 2021. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

Blueshift Asset Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
Blueshift Asset Management sold 5,550 Zimmer Biomet shares in Q3 2024, an estimated $602K.
Blueshift Asset Management first reported a position in Zimmer Biomet in Q4 2018 and held it in 9 quarters.
Blueshift Asset Management's Zimmer Biomet position peaked at $8.1M in Q2 2021.
981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Blueshift Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.